XML 25 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Disclosures
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Disclosures

8. Segment Disclosures

The Company operates as a single operating segment. The Company's chief operating decision maker (CODM) is its chief executive officer, who reviews financial information presented on a consolidated basis. The CODM uses consolidated net income (loss) to assess financial performance and allocate resources. The CODM does not review assets in evaluating the results of the single segment and therefore, such information is not presented.

The following table presents selected financial information with respect to the Company's single operating segment for the three months ended March 31, 2025 and 2024:

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Revenue

 

$

52

 

 

$

529

 

Less:

 

 

 

 

 

 

Research and development

 

 

 

 

 

 

Clinical and manufacturing

 

 

23,065

 

 

 

14,226

 

Other research and development(1)

 

 

4,402

 

 

 

2,984

 

Total research and development

 

 

27,467

 

 

 

17,210

 

General and administrative

 

 

14,789

 

 

 

5,788

 

Total operating expenses

 

 

42,256

 

 

 

22,998

 

Loss from operations

 

 

(42,204

)

 

 

(22,469

)

Other income, net

 

 

7,752

 

 

 

5,535

 

Net loss

 

$

(34,452

)

 

$

(16,934

)

 
 
(1) Other research and development consists of indirect costs incurred for the benefit of the research and development efforts, including certain personnel, supply chain, quality assurance, and regulatory affairs.